MDT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Stats
Today's Volume	4.19M
Average Volume	6.39M
Market Cap	107.94B
EPS	$0 ( 2024-04-07 )
Next earnings date	( $1.450 ) 2024-05-23
Last Dividend	$0.690 ( 2023-09-21 )
Next Dividend	$0 ( N/A )
P/E	25.81
ATR14	$0.0350 (0.04%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Marinaro Michael	Sell	854	Ordinary Shares
2024-03-05	Marinaro Michael	Sell	563	Ordinary Shares
2024-02-21	Salmon Sean	Buy	16 035	Ordinary Shares
2024-02-21	Salmon Sean	Sell	1 594	Ordinary Shares
2024-02-21	Salmon Sean	Sell	13 066	Ordinary Shares

INSIDER POWER
65.39
Last 100 transactions
Buy: 1 272 294 \| Sell: 350 051

Volume Correlation

Long: 0.37 (neutral)

Short: 0.85 (strong)

Signal:(70.31) Same movement expected

Medtronic PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medtronic PLC Correlation - Currency/Commodity

0.35
( neutral )

0.11
( neutral )

0.00
( neutral )

0.06
( neutral )

0.16
( neutral )

0.51
( weak )

Medtronic PLC Financials

Annual	2023
Revenue:	$31.23B
Gross Profit:	$20.51B (65.67 %)
EPS:	$2.85

Q3	2024
Revenue:	$8.09B
Gross Profit:	$5.31B (65.61 %)
EPS:	$0.990

Q2	2024
Revenue:	$7.98B
Gross Profit:	$5.22B (65.42 %)
EPS:	$0.680

Q1	2024
Revenue:	$7.70B
Gross Profit:	$5.07B (65.88 %)
EPS:	$0.590

Financial Reports:

No articles found.

Medtronic PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.680 (N/A)	$0.680 (N/A)	$0.680 (N/A)	$0.690 (N/A)	$0.690 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Medtronic PLC Dividend Information - Dividend King

Dividend Sustainability Score: 9.19 - good (91.95%) | Divividend Growth Potential Score: 3.66 - Decrease likely (26.78%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00219	1982-01-04
Last Dividend	$0.690	2023-09-21
Next Dividend	$0	N/A
Payout Date	2023-10-13
Next Payout Date	N/A
# dividends	167	--
Total Paid Out	$27.99	--
Avg. Dividend % Per Year	1.62%	--
Score	5.08	--
Div. Sustainability Score	9.19
Div.Growth Potential Score	3.66
Div. Directional Score	6.43	--

Next Divdend (Est)
(2024-07-31)

$0.698 Estimate 21.86 %

Dividend Stability

0.58 Average

Dividend Score

5.08

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1982	$0.00938	1.55%
1983	$0.0106	1.26%
1984	$0.0116	1.72%
1985	$0.0122	2.89%
1986	$0.0131	1.94%
1987	$0.0150	1.24%
1988	$0.0134	0.90%
1989	$0.0203	1.67%
1990	$0.0238	1.16%
1991	$0.0286	1.09%
1992	$0.0325	0.56%
1993	$0.0387	0.65%
1994	$0.0595	1.15%
1995	$0.0454	0.68%
1996	$0.0802	0.62%
1997	$0.103	0.61%
1998	$0.120	0.48%
1999	$0.145	0.40%
2000	$0.181	0.53%
2001	$0.215	0.36%
2002	$0.299	0.60%
2003	$0.280	0.60%
2004	$0.243	0.50%
2005	$0.362	0.73%
2006	$0.413	0.71%
2007	$0.470	0.89%
2008	$0.813	1.64%
2009	$0.598	1.83%
2010	$0.860	1.96%
2011	$0.936	2.50%
2012	$1.266	3.27%
2013	$1.100	2.63%
2014	$1.195	2.09%
2015	$1.445	2.01%
2016	$1.670	2.20%
2017	$1.810	2.56%
2018	$1.460	1.78%
2019	$2.12	2.41%
2020	$2.28	1.99%
2021	$2.47	2.13%
2022	$2.67	2.52%
2023	$2.06	2.63%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.130	1.500	7.40	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0462	1.200	8.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0816	1.500	-0.204	-0.307	[0.1 - 1]
payoutRatioTTM	0.871	-1.000	1.293	-1.293	[0 - 1]
currentRatioTTM	2.30	0.800	3.51	2.80	[1 - 3]
quickRatioTTM	1.459	0.800	6.12	4.90	[0.8 - 2.5]
cashRatioTTM	0.166	1.500	-0.190	-0.286	[0.2 - 2]
debtRatioTTM	0.277	-1.500	5.39	-8.08	[0 - 0.6]
interestCoverageTTM	8.05	1.000	8.13	8.13	[3 - 30]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.71	2.00	8.15	10.00	[0 - 20]
debtEquityRatioTTM	0.485	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.655	1.000	2.42	2.42	[0.2 - 0.8]
operatingProfitMarginTTM	0.175	1.000	8.50	8.50	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.258	1.000	9.68	9.68	[0.2 - 2]
assetTurnoverTTM	0.356	0.800	-0.961	-0.769	[0.5 - 2]
Total Score				9.19

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.73	1.000	7.50	0	[1 - 100]
returnOnEquityTTM	0.0816	2.50	-0.131	-0.307	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
dividendYielPercentageTTM	3.40	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
payoutRatioTTM	0.871	1.500	1.293	-1.293	[0 - 1]
pegRatioTTM	-1.049	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.200	1.000	7.50	0	[0.1 - 0.5]
Total Score				3.66

Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.